<DOC>
	<DOCNO>NCT01671007</DOCNO>
	<brief_summary>In part Registry Program patient non-valvular atrial fibrillation ( AF ) risk stroke enrolled characterize target population collect real world data important outcome event . For administrative purpose study divide two protocol number : 1160.129 non-EU ( European Union ) non-EEA ( European Economic Area ) country , 1160.136 EU EEA country . The total number patient enrol protocol estimate 48,000 patient , patient include data analysis study 1160.129 .</brief_summary>
	<brief_title>GLORIA-AF Registry Program ( Phase II/III - EU/EEA Member States )</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Inclusion criterion : 1 . Age = &gt; 18 year enrollment 2 . Male female patient ( legally acceptable representative ) willing able provide write informed consent 3 . Patient newly diagnose ( &lt; 3 month prior baseline visit ) nonvalvular AF risk stroke . Other inclusion criterion apply . Exclusion criterion : 1 . Presence mechanical heart valve , valve disease expect require valve replacement intervention ; 2 . Patients receive 60 day vitamin K antagonist ( VKA ) treatment lifetime ; 3 . AF generally reversible cause ; 4 . Patients medical condition atrial fibrillation chronic use oral anticoagulant ( example , VKA ) indicate Other exclusion criterion apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>